enVVeno Medical (NVNO) EPS (Weighted Average and Diluted) (2022 - 2026)

enVVeno Medical's EPS (Weighted Average and Diluted) history runs 5 years deep, the most recent figure standing at -$5.89 for Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) rose 24.0% year-over-year to -$5.89; the TTM figure through Mar 2026 stood at -$38.73 (up 25.48% YoY), while the FY2025 annual figure was -$33.06, up 25.76% from the prior year.
• EPS (Weighted Average and Diluted) was -$5.89 for Q1 2026 at enVVeno Medical, up from -$32.28 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.23 in Q3 2025 to a low of -$43.56 in Q4 2024.
• Historically, EPS (Weighted Average and Diluted) has averaged -$5.92 across 5 years, with a median of -$0.55 in 2022.
• Biggest YoY gain for EPS (Weighted Average and Diluted) was 46.55% in 2024; the steepest drop was 13512.5% in 2024.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.55 in 2022, then soared by 41.82% to -$0.32 in 2023, then tumbled by 13512.5% to -$43.56 in 2024, then climbed by 25.9% to -$32.28 in 2025, then jumped by 81.75% to -$5.89 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at -$5.89 (Q1 2026), -$32.28 (Q4 2025), and -$0.23 (Q3 2025), per Business Quant data.